Artivion, Inc. (AORT)
19.10
-0.30
(-1.55%)
USD |
NYSE |
Nov 13, 16:00
19.10
0.00 (0.00%)
Pre-Market: 19:59
Artivion Net Income (Quarterly) : -7.916M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -7.916M |
| June 30, 2026 | -13.49M |
| March 31, 2026 | 1.416M |
| December 31, 2025 | 2.424M |
| September 30, 2025 | 6.495M |
| June 30, 2025 | 1.343M |
| March 31, 2025 | -0.504M |
| December 31, 2024 | -16.45M |
| September 30, 2024 | -2.285M |
| June 30, 2024 | -2.117M |
| March 31, 2024 | 7.511M |
| December 31, 2023 | -3.96M |
| September 30, 2023 | -9.762M |
| June 30, 2023 | -3.37M |
| March 31, 2023 | -13.47M |
| December 31, 2022 | 2.158M |
| September 30, 2022 | -13.64M |
| June 30, 2022 | -4.238M |
| March 31, 2022 | -3.371M |
| December 31, 2021 | -19.97M |
| September 30, 2021 | 10.52M |
| June 30, 2021 | -2.164M |
| March 31, 2021 | -3.115M |
| December 31, 2020 | -3.44M |
| September 30, 2020 | -2.85M |
| Date | Value |
|---|---|
| June 30, 2020 | -3.665M |
| March 31, 2020 | -6.622M |
| December 31, 2019 | -0.676M |
| September 30, 2019 | -0.133M |
| June 30, 2019 | 2.813M |
| March 31, 2019 | -0.295M |
| December 31, 2018 | -1.734M |
| September 30, 2018 | 1.55M |
| June 30, 2018 | 0.224M |
| March 31, 2018 | -3.817M |
| December 31, 2017 | -3.007M |
| September 30, 2017 | 1.303M |
| June 30, 2017 | 3.101M |
| March 31, 2017 | 2.179M |
| December 31, 2016 | 2.841M |
| September 30, 2016 | 2.935M |
| June 30, 2016 | 2.301M |
| March 31, 2016 | 2.493M |
| December 31, 2015 | 2.636M |
| September 30, 2015 | 2.145M |
| June 30, 2015 | -0.491M |
| March 31, 2015 | -0.267M |
| December 31, 2014 | 1.727M |
| September 30, 2014 | 2.273M |
| June 30, 2014 | 2.123M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 920.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -5.471M |
| AtriCure, Inc. | 4.064M |
| Baxter International, Inc. | 298.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 123.79M |
| Total Expenses (Quarterly) | 131.71M |
| EPS Diluted (Quarterly) | -0.1625 |
| Enterprise Value | 1.291B |
| Gross Profit Margin (Quarterly) | 57.52% |
| Profit Margin (Quarterly) | -6.39% |
| Earnings Yield | -1.90% |
| Operating Earnings Yield | 2.52% |
| Normalized Earnings Yield | -0.6162 |